Writing About Experiences With Ovarian Cancer

Sponsor
University of Maryland, College Park (Other)
Overall Status
Completed
CT.gov ID
NCT02593422
Collaborator
(none)
73
1
2
20
3.6

Study Details

Study Description

Brief Summary

This online study aims to understand whether writing about one's experiences with ovarian cancer may be beneficial for psychological and physical wellbeing in women with a history of ovarian cancer. Investigators are also interested in studying how certain individual characteristics may impact the effectiveness of writing. Participants will be asked to complete an initial survey (15 min), followed by writing about their experiences with ovarian cancer on four occasions (20 - 25 min each), over the course of two weeks. A final survey (10 min) will be completed one month afterwards.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Expressive Writing
  • Behavioral: Fact Writing (Control)
N/A

Detailed Description

The purpose of this randomized controlled experiment is to examine the effects of writing about experiences with ovarian cancer on psychological and physical outcomes in English-speaking women with a history of ovarian cancer. It will also examine how certain individual characteristics may impact the effectiveness of the writing interventions for different women. After completing an initial survey, women will be asked to write about their experiences with ovarian cancer on 4 separate occasions of 20-25 min each in the course of 2 weeks. A final survey will be completed one month after the last writing session. The entire study will be conducted online.

Study Design

Study Type:
Interventional
Actual Enrollment :
73 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Supportive Care
Official Title:
Writing About Experiences With Ovarian Cancer
Study Start Date :
Apr 1, 2015
Actual Primary Completion Date :
Dec 1, 2016
Actual Study Completion Date :
Dec 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Expressive Writing

Writing about ovarian cancer: Participants will be asked to write about their deepest thoughts and emotions about their experience with ovarian cancer

Behavioral: Expressive Writing
Participants will be asked to write about their deepest thoughts and emotions about their experience with ovarian cancer

Active Comparator: Fact Writing (Control)

Writing about ovarian cancer: Participants will be asked to write about the facts of their experience with ovarian cancer

Behavioral: Fact Writing (Control)
Participants will be asked to write about the facts of their experience with ovarian cancer

Outcome Measures

Primary Outcome Measures

  1. Change in Psychological Functioning (Wellbeing/Distress) [6 - 9 weeks, with timely completion of writing: Initial survey (day 1), after 2nd writing task (week 1), after 4th writing task (week 2), and one month after last writing task (week 6)]

    Various aspects of social, emotional and functional wellbeing will be assessed using the Functional Assessment of Cancer-Ovarian measure (FACT-O, Version 4, Basen-Engquist et al, 2001). Distress about ovarian cancer will be assessed using the Impact of Event Scale (IES, Horowitz, Wilner & Alvarez, 1979).

Secondary Outcome Measures

  1. Change in Physical Wellbeing [6 - 9 weeks, with timely completion of writing: Initial survey (day 1), after 2nd writing task (week 1), after 4th writing task (week 2), and one month after last writing task (week 6)]

    Physical symptoms and concerns specific to ovarian cancer will be assessed using Functional Assessment of Cancer - Ovarian (FACT-O, Version 4, Basen-Engquist et al, 2001).

  2. Changes in affect before and after writing about ovarian cancer [Prior to and after each of 4 writing tasks (weeks 1 - 2)]

    Positive and negative affect will be assessed using the Positive and Negative Affect Scale (PANAS, Watson, Clark & Tellegen, 1988).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women with a history of ovarian cancer (any stage)

  • At least 18 years old

  • English-speaking/Can comfortably read and write in English

  • Able to provide informed consent

  • Internet access

  • Valid email address

  • Any region/country

Exclusion Criteria:
  • Minors (younger than 18)

  • Lack of English proficiency

  • Inability to provide informed consent

  • Male

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Maryland, College Park College Park Maryland United States 20742

Sponsors and Collaborators

  • University of Maryland, College Park

Investigators

  • Study Chair: Mary Ann Hoffman, Ph.D., University of Maryland, College Park

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of Maryland, College Park
ClinicalTrials.gov Identifier:
NCT02593422
Other Study ID Numbers:
  • 728101-3
First Posted:
Nov 1, 2015
Last Update Posted:
May 23, 2022
Last Verified:
May 1, 2022
Keywords provided by University of Maryland, College Park
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 23, 2022